Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® Blood-borne specialty page provides blood-borne-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

BLOOD-BORNE DISEASES VIDEOS - Page 2

How Has the Ebola Virus Response Impacted CDC's Response to Zika?
Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response at the Centers for Disease Control and Prevention (CDC) explains what the CDC learned from responding to the Ebola outbreak and how this has impacted the response to the Zika virus.
Direct-Acting Antiviral's Impact on Patients' Adherence to HCV Drug Regimen
Charitha Gowda, MD, MPH, infectious diseases physician at Penn Presbyterian Medical Center discusses the impact direct-acting antivirals have had on patients’ adherence to their drug regimen when treating hepatitis C.
How Does the Treatment Regimen Differ for Acute HCV vs. Chronic HCV?
Charitha Gowda, MD, MPH, Infectious diseases physician at Penn Presbyterian Medical Center explains how  the treatment regimen for treating those with acute hepatitis C differs from chronic hepatitis C.
Evaluation and Treatment of Hepatitis C
Charitha Gowda, MD, MPH, Infectious diseases physician at Penn Presbyterian Medical Center explains the process for the evaluation of hepatitis C, leading up to treatment.
What Are the Prevention Methods for Hepatitis C?
Charitha Gowda, MD, MPH, discusses the current and upcoming methods to prevent hepatitis C.
HIV / HCV Coinfection
Charitha Gowda, MD, MPH, explains why we see such a high incidence of HIV / HCV coinfection.
Discussing the VA's Decision To Supply HCV Treatment to All Veterans
Charitha Gowda, MD MPH, infectious diseases physician at Penn Presbyterian Medical Center discusses the recent decision from The Department of Veterans Affairs (VA) to supply hepatitis C (HCV) treatment to all veterans, regardless of disease stage.
What Are The Barriers to HCV Treatment?
Charitha Gowda, MD MPH, infectious diseases physician at Penn Presbyterian Medical Center, explains the barriers to hepatitis C (HCV) treatment.
FEATURED
Big advances in treatment can